IE39213B1 - New pyrazol 5-ones their preparation and their pharmaceutical use - Google Patents
New pyrazol 5-ones their preparation and their pharmaceutical useInfo
- Publication number
- IE39213B1 IE39213B1 IE799/74A IE79974A IE39213B1 IE 39213 B1 IE39213 B1 IE 39213B1 IE 799/74 A IE799/74 A IE 799/74A IE 79974 A IE79974 A IE 79974A IE 39213 B1 IE39213 B1 IE 39213B1
- Authority
- IE
- Ireland
- Prior art keywords
- substituted
- carbon atoms
- hydrogen
- ethylene
- alkyl
- Prior art date
Links
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 title 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 6
- -1 1-Substituted pyrazole-5-ones Chemical class 0.000 abstract 5
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 2
- 239000005977 Ethylene Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical group C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000001570 methylene group Chemical class [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2319279A DE2319279A1 (de) | 1973-04-17 | 1973-04-17 | Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2363138A DE2363138A1 (de) | 1973-12-19 | 1973-12-19 | Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE39213L IE39213L (en) | 1974-10-17 |
| IE39213B1 true IE39213B1 (en) | 1978-08-30 |
Family
ID=25764995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE799/74A IE39213B1 (en) | 1973-04-17 | 1974-04-17 | New pyrazol 5-ones their preparation and their pharmaceutical use |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3952008A (ro) |
| JP (1) | JPS59512B2 (ro) |
| AR (2) | AR207445A1 (ro) |
| BG (2) | BG22394A3 (ro) |
| CA (1) | CA1048513A (ro) |
| CH (2) | CH605799A5 (ro) |
| DD (1) | DD113230A5 (ro) |
| DK (1) | DK136155C (ro) |
| ES (2) | ES425374A1 (ro) |
| FR (1) | FR2226171B1 (ro) |
| GB (1) | GB1424492A (ro) |
| HK (1) | HK55876A (ro) |
| HU (1) | HU168591B (ro) |
| IE (1) | IE39213B1 (ro) |
| IL (1) | IL44627A (ro) |
| LU (1) | LU69871A1 (ro) |
| NL (1) | NL7405116A (ro) |
| NO (1) | NO139439C (ro) |
| PL (1) | PL96880B1 (ro) |
| RO (2) | RO69408A (ro) |
| SE (1) | SE408552B (ro) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30420E (en) * | 1973-04-17 | 1980-10-21 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
| US4056533A (en) * | 1973-04-17 | 1977-11-01 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
| DE2319278C2 (de) * | 1973-04-17 | 1986-02-20 | Bayer Ag, 5090 Leverkusen | Pharmazeutisches Mittel |
| US4000294A (en) * | 1973-04-17 | 1976-12-28 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
| DE2427272C3 (de) * | 1974-06-06 | 1981-10-01 | Bayer Ag, 5090 Leverkusen | 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum |
| DE2526469A1 (de) * | 1975-06-13 | 1976-12-30 | Bayer Ag | 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| JPS5585571A (en) * | 1978-12-22 | 1980-06-27 | Nippon Synthetic Chem Ind Co Ltd:The | Preparation of 1,3-disubstituted-5-pyrazolone |
| JPH0730031B2 (ja) * | 1986-04-02 | 1995-04-05 | 日産化学工業株式会社 | ２―ピラゾリン―５―オン類の製造法 |
| WO2006094201A2 (en) * | 2005-03-02 | 2006-09-08 | La Jolla Pharmaceutical Company | Semicarbazide-sensitive amide oxidase inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2376380A (en) * | 1945-05-22 | Preparation of amino pyrazolones | ||
| GB636988A (en) * | 1947-12-24 | 1950-05-10 | Gevaert Photo Producten Naamlo | Improvements in and relating to the production of colour photographic images |
| US2511231A (en) * | 1949-03-26 | 1950-06-13 | Eastman Kodak Co | 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography |
| US2600788A (en) * | 1949-06-07 | 1952-06-17 | Eastman Kodak Co | Halogen-substituted pyrazolone couplers for color photography |
| US2672417A (en) * | 1949-12-31 | 1954-03-16 | Gevaert Photo Prod Nv | Production of color photographic images |
| NL121416C (ro) * | 1961-05-31 |
-
1974
- 1974-01-01 AR AR253332A patent/AR207445A1/es active
- 1974-03-29 FR FR7411445A patent/FR2226171B1/fr not_active Expired
- 1974-04-10 HU HUBA3059A patent/HU168591B/hu unknown
- 1974-04-12 BG BG026396A patent/BG22394A3/xx unknown
- 1974-04-12 IL IL44627A patent/IL44627A/xx unknown
- 1974-04-12 BG BG029509A patent/BG22820A3/xx unknown
- 1974-04-15 DD DD177899A patent/DD113230A5/xx unknown
- 1974-04-15 RO RO7485080A patent/RO69408A/ro unknown
- 1974-04-15 JP JP49041113A patent/JPS59512B2/ja not_active Expired
- 1974-04-15 RO RO7478423A patent/RO63750A/ro unknown
- 1974-04-15 US US05/461,285 patent/US3952008A/en not_active Expired - Lifetime
- 1974-04-16 NL NL7405116A patent/NL7405116A/xx not_active Application Discontinuation
- 1974-04-16 CH CH156777A patent/CH605799A5/xx not_active IP Right Cessation
- 1974-04-16 PL PL74170386A patent/PL96880B1/pl unknown
- 1974-04-16 NO NO741364A patent/NO139439C/no unknown
- 1974-04-16 LU LU69871A patent/LU69871A1/xx unknown
- 1974-04-16 SE SE7405079A patent/SE408552B/xx unknown
- 1974-04-16 CH CH524374A patent/CH603593A5/xx not_active IP Right Cessation
- 1974-04-16 ES ES425374A patent/ES425374A1/es not_active Expired
- 1974-04-16 DK DK207974A patent/DK136155C/da active
- 1974-04-17 GB GB1678474A patent/GB1424492A/en not_active Expired
- 1974-04-17 CA CA74197658A patent/CA1048513A/en not_active Expired
- 1974-04-17 IE IE799/74A patent/IE39213B1/xx unknown
-
1975
- 1975-01-01 AR AR258463A patent/AR207242A1/es active
-
1976
- 1976-04-15 ES ES447081A patent/ES447081A1/es not_active Expired
- 1976-09-08 HK HK558/76*UA patent/HK55876A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO139439C (no) | 1979-03-14 |
| NO741364L (no) | 1974-10-18 |
| CA1048513A (en) | 1979-02-13 |
| NL7405116A (ro) | 1974-10-21 |
| LU69871A1 (ro) | 1974-11-21 |
| DD113230A5 (ro) | 1975-05-20 |
| NO139439B (no) | 1978-12-04 |
| CH603593A5 (ro) | 1978-08-31 |
| HK55876A (en) | 1976-09-17 |
| ES447081A1 (es) | 1977-06-16 |
| AU6817574A (en) | 1975-10-23 |
| SE408552B (sv) | 1979-06-18 |
| JPS5012082A (ro) | 1975-02-07 |
| FR2226171A1 (ro) | 1974-11-15 |
| BG22820A3 (bg) | 1977-04-20 |
| US3952008A (en) | 1976-04-20 |
| BG22394A3 (bg) | 1977-02-20 |
| IL44627A (en) | 1978-07-31 |
| AR207242A1 (es) | 1976-09-22 |
| HU168591B (ro) | 1976-06-28 |
| DK136155B (da) | 1977-08-22 |
| PL96880B1 (pl) | 1978-01-31 |
| IE39213L (en) | 1974-10-17 |
| DK136155C (da) | 1978-01-30 |
| RO69408A (ro) | 1980-06-15 |
| CH605799A5 (ro) | 1978-10-13 |
| IL44627A0 (en) | 1974-06-30 |
| FR2226171B1 (ro) | 1978-07-28 |
| JPS59512B2 (ja) | 1984-01-07 |
| GB1424492A (en) | 1976-02-11 |
| AR207445A1 (es) | 1976-10-08 |
| RO63750A (ro) | 1980-06-15 |
| ES425374A1 (es) | 1976-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES422395A1 (es) | Un procedimiento para la preparacion de cinamamidas e hi- drocinamamidas. | |
| AU6128590A (en) | Novel compounds | |
| IE41528L (en) | Furfuryl-benzomorphane derivatives. | |
| GB1392275A (en) | Therapeutic compositions | |
| IE40409B1 (en) | Novel 2,6-dusubstituted phenyl-aminoguanidine compounds | |
| IE39213B1 (en) | New pyrazol 5-ones their preparation and their pharmaceutical use | |
| GB1433701A (en) | 5-6-benzene ring substituted benzimidazole-2-carbamate derivative having anthelmintic activity apparatus | |
| IE41440L (en) | Thiatetracyclines | |
| IE40335L (en) | Pyrazole derivatives | |
| IE40742B1 (en) | 1,3-diketo-1,2,3,4-tetrahydroisoquinolines | |
| ES8700253A1 (es) | Procedimiento para preparar compuestos de 5-alquil-1-fenil- -2-piperazinoalquilpirazolin-3-ona | |
| IE39577B1 (en) | Pharmaceutical compositions | |
| IE37269B1 (en) | 1-aminosulphonyl-2-aminobenzimidazoles process for their preparation and their fungicidal use | |
| IE38979L (en) | Tetrazolyl - quinoxalinecarboxamide derivatives | |
| GB1164108A (en) | Desglucohellebrin Derivatives | |
| IE40195B1 (en) | New - lactam antibiotic compounds, their production and their medicinal use | |
| ES444369A1 (es) | Procedimiento de preparacion de nuevos derivados dienicos dela serie del androstano. | |
| IE44184L (en) | Imidazole derivatives | |
| IE39576L (en) | DERIVATIVES OF 3- (p-CHLOROBENZOYL)-2-METHYL- PHENYLACETIC¹ACID | |
| GB1322987A (en) | On,n-diacylhydroxylamine derivatives and preparation | |
| IE41462L (en) | Piperidyl-methylenedioxybenzene derivatives. | |
| GB1394791A (en) | Diphenylalkyllactamimide derivatives | |
| IE39853B1 (en) | New n'-(aminoacylaminophenyl)-acetamidines and salts thereof their production and their medicinal use | |
| IE44789L (en) | Benzimidazole-2-carbamate derivatives | |
| GB1146183A (en) | Improvements in or relating to nicotinamide derivatives having an analgesic, anti-inflammatory, antipyretic and anti-histaminic action, method for their preparation, andtherapeutical use |